D-1576-2014 Class II Terminated
FDA drug recall D-1576-2014 was initiated by Apotex Inc. on Mar 24, 2014 and is designated Class II. Reason for recall: Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents. The recall status is terminated (terminated Sep 23, 2014).
Recall details
- Product Type
- Drugs
- Report Date
- Sep 10, 2014
- Initiation Date
- Mar 24, 2014
- Termination Date
- Sep 23, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Paroxetine HCL Controlled-Release Tablets 25 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3674-3
Reason for recall
Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot # 2A002, Exp. 01/15 Lot # 2A003, Exp. 01/15 Lot # 2C004, Exp. 03/15 Lot # 2C005, Exp. 03/15 Lot # 2E008, Exp. 05/15 Lot # 2F009, Exp. 06/15 Lot # 2F010, Exp. 06/15 Lot # 2H011, Exp. 08/15 Lot # 2H012, Exp. 08/15 Lot # 2H013, Exp. 0815
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1576-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026